Gilead Sciences
GILD
#93
Rank
NZ$308.58 B
Marketcap
NZ$248.57
Share price
-0.76%
Change (1 day)
22.49%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.23

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$10.99. In 2024 the company made an earnings per share (EPS) of NZ$0.64 a decrease over its 2023 EPS that were of NZ$7.67.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.231652.13%
2024NZ$0.64-91.65%
2023NZ$7.6723.98%
2022NZ$6.19-25.86%
2021NZ$8.354850%
2020NZ$0.17-97.64%
2019NZ$7.150.9%
2018NZ$7.0918.71%
2017NZ$5.97-64.88%
2016NZ$17.00-18.45%
2015NZ$20.8455.28%
2014NZ$13.42296.02%
2013NZ$3.3917.89%
2012NZ$2.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.78 70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.29-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.03-63.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.81 253.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.16 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.53 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.54-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$24.16 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.32 12.07%๐Ÿ‡บ๐Ÿ‡ธ USA